Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair thinning during Wegovy treatment is real, common in women, and in most cases temporary. It typically emerges two to four months after starting semaglutide and is closely linked to the physical stress of rapid weight loss rather than a direct toxic effect of the medicine itself. Wegovy is a prescription-only weight-loss treatment and any concerns about hair changes should be raised with your prescribing clinician. The steps below won't reverse the biology overnight, but they do make a measurable difference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether Wegovy itself is stripping the hair out. The honest answer is: not directly. What is happening in most women is telogen effluvium, a recognised physiological response in which physical or nutritional stress pushes follicles prematurely into their resting phase. A few months later, those resting hairs shed at once. The specific female pattern of hair loss on Wegovy follows this timing almost exactly: treatment starts, appetite drops sharply, calorie and protein intake falls, and by month three or four the mirror tells a different story.
Rapid weight loss is a well-documented trigger for this cycle regardless of how it is achieved. The NHS medicines page for semaglutide lists hair loss as a known side effect worth discussing with your doctor, placing it firmly in the manageable category rather than the dangerous one. Knowing the mechanism matters because it changes the response: this is a nutritional and physiological problem, and that is where the most effective interventions sit.
It also means that simply stopping Wegovy is unlikely to be the right answer for most women. The shed will often slow once weight stabilises (even at the same dose) because the biological stress signal quietens. Stopping and restarting can, paradoxically, trigger another round of shedding.
Once appetite falls significantly on semaglutide, it takes deliberate planning to meet the nutritional thresholds that follicles need. Most clinical guidance on weight-loss medicines recommends a daily protein target in the region of 1.2–1.6 g per kilogram of body weight, though your prescriber or dietitian is the right person to personalise that figure.
In practice, that means prioritising protein at every meal before filling up on lower-density foods: eggs, Greek yoghurt, fish, chicken, legumes, cottage cheese. Small portions feel large quickly on Wegovy, so protein should come first on the plate. Alongside protein, iron, zinc, vitamin D, and B vitamins are the micronutrients most frequently implicated in hair-cycle disruption. A standard multivitamin covering these bases is reasonable; a targeted supplement like biotin is widely used, though the evidence for biotin specifically in telogen effluvium is modest.
Hydration matters more than it sounds. The GI effects of semaglutide (nausea and reduced appetite together) can reduce fluid intake considerably. Staying well hydrated supports circulation to the scalp and general cellular function. Our guide to managing nausea on Wegovy covers practical strategies for keeping food and fluid intake on track when the medicine's appetite suppression is at its strongest.
Follicles already transitioning into telogen are more fragile. Mechanical stress (aggressive brushing, tight ponytails, extensions, heat styling, and harsh chemical treatments) can worsen the visible shed without influencing the underlying biology. The adaptations here are simple and low-cost.
Use a wide-toothed comb on damp hair rather than a fine-bristled brush. Loosen habitual tight styles. If you colour or chemically treat your hair, spacing those appointments further apart during the peak shed phase reduces breakage at the shaft. Scalp massage has a small evidence base for stimulating blood flow to follicles and is unlikely to cause harm; a few minutes of gentle circular pressure when washing is a reasonable addition. Minoxidil, available over the counter, is licensed for female-pattern hair loss and has a stronger evidence base than most topical products, but its use alongside prescription weight-loss treatment is worth discussing with your GP or prescriber before you start.
If you want to understand the broader picture of hair loss as a Wegovy side effect, including how it compares across different users, that page goes into more detail on who is most likely to experience it and how long it typically lasts.
Most Wegovy-related hair thinning in women resolves within six to nine months of weight stabilising, without any change to treatment. But there are signs that should prompt a GP appointment rather than patience. Seek medical attention if: the hair loss is patchy or asymmetric rather than diffuse; shedding is still accelerating after six months on a stable dose; you develop scalp irritation, inflammation, or visible changes to the scalp skin; or the loss is affecting eyebrows, eyelashes, or body hair (which would point away from telogen effluvium).
A GP can check ferritin (iron stores), thyroid function, and zinc levels, deficiencies in any of these can run alongside weight-loss treatment and contribute independently to shedding. Female-pattern androgenetic alopecia can also be unmasked or accelerated by hormonal shifts during significant weight change and has its own treatment pathway.
If you suspect a side effect you weren't warned about, or if the hair loss feels unusually severe, you can report it directly through the MHRA Yellow Card scheme, that reporting system is how regulators track patterns across thousands of patients and update safety guidance. You can also review the full side effects profile of Wegovy to see where hair thinning sits relative to other reported effects and how each is managed. For those experiencing other skin-related changes, our page on Wegovy and skin rash covers what's known there too.
Our prescribers discuss side effects including hair changes as part of every consultation. If you'd like to explore whether semaglutide treatment is clinically suitable for you, you can check your eligibility through a free consultation, same-day clinical review, no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.